Lupin gets FDA nod for generic Lipitor
Lupin has received the Food and Drug Administration’s green light for atorvastatin calcium tablets, in 10 mg, 20 mg, 40 mg, and 80 mg, dosage strengths.
The product is a generic of Pfize’s Lipitor tablets, 10 mg, 20 mg, 40 mg and 80 mg.
It is indicated to lower cholesterol in blood for adults and children over 10 years of age. Atorvastatin is also prescribed to lower the risk for heart attack, stroke in patients with cardiovascular diseases, diabetes and other risk factors such as eye problems, kidney diseases or high blood pressure.
Atorvastatin calcium tablets, 10 mg, 20 mg, 40 mg, and 80 mg had a market value of approximately $696 million, according to December 2018 data.
The product is a generic of Pfize’s Lipitor tablets, 10 mg, 20 mg, 40 mg and 80 mg.
It is indicated to lower cholesterol in blood for adults and children over 10 years of age. Atorvastatin is also prescribed to lower the risk for heart attack, stroke in patients with cardiovascular diseases, diabetes and other risk factors such as eye problems, kidney diseases or high blood pressure.
Atorvastatin calcium tablets, 10 mg, 20 mg, 40 mg, and 80 mg had a market value of approximately $696 million, according to December 2018 data.